NCT00688896
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
- Locations
-
- Amsterdam, Netherlands
Clinical trial condition
Hyperlipoproteinemia Type II
Explore clinical trials studying Hyperlipoproteinemia Type II. Study availability and eligibility vary by location and protocol.
176 public trials
31 recruiting studies
Hyperlipoproteinemia Type II trial results
NCT00686010
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
- Locations
-
- Amsterdam, Utrecht, Rotterdam, Nijmegen, Arnhem, Groningen, Dordrecht, Hoorn, Groningen Amsterdam, Netherlands
NCT00134511
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
- Locations
-
- Pfizer Investigational Site Boston, Massachusetts, United States
- Pfizer Investigational Site Chicoutimi, Quebec, Canada
- Pfizer Investigational Site Ste-Foy, Quebec, Canada
- Pfizer Investigational Site Parktown, Johannesburg, South Africa
NCT00134485
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
- Locations
-
- Pfizer Investigational Site San Diego, California, United States
- Pfizer Investigational Site Washington D.C., District of Columbia, United States
- Pfizer Investigational Site Lutz, Florida, United States
- Pfizer Investigational Site Tampa, Florida, United States
NCT00345657
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemia, Dyslipidemias, +11 more
- Locations
-
- Family Medical Care of Tulsa Tulsa, Oklahoma, United States
NCT00004809
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disease Attributes, Dyslipidemias, +13 more
- Locations
-
Not specified